Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Kissei Pharmaceutical Co ( (JP:4547) ) is now available.
Kissei Pharmaceutical reported a 4.9% increase in net sales for the three months ending June 30, 2025, compared to the same period in the previous year. Despite the rise in sales, the operating profit saw a slight decline of 2.3%. The company forecasts a modest growth in profit attributable to owners for the fiscal year ending March 31, 2026, indicating a stable outlook amidst industry challenges.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen3600.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily engaged in the pharmaceutical industry. The company focuses on the development and sale of pharmaceutical products, catering to various healthcare needs.
Average Trading Volume: 94,758
Technical Sentiment Signal: Buy
Current Market Cap: Yen176.9B
Learn more about 4547 stock on TipRanks’ Stock Analysis page.